Cardiovascular Diabetology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2024-03-08 ms1000000262909438 来自湖北省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：糖尿病心血管
经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍

471 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2020-08-04 ms1000001187261143

已经投稿7天了，状态还是new submission，是不是还没到编辑手里？

1572 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2024-05-08 ms8000001858743317 来自北京

请问大家现在是先校稿，再付版面费吗？

75 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2023-11-24 ms6000000946453986 来自山东省

偏重的研究方向：血脂;糖尿病
经验分享：有没有被接受的基础研究文章啊

497 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2023-12-25 好吃猫111 来自广东省

甲状腺激素的可以投么？

442 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2023-02-07 jaimewang 来自山西省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：内分泌
经验分享：希望今年IF能破10啊

308 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2022-11-10 木帆

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：心血管;糖尿病
经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高

555 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2021-12-29 小动量

关键词筛选有什么要求？

3322 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2021-12-29 MS54455111222

关键词最多不能超过多少个？

3278 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2191973, encodeId=568421919e3dc, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病心血管 经验分享：已经修回了显示The editors' decision can take several weeks as they may consult peer reviewers.，看到说有再邀请审稿人的然后再重新修一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606d8993093, createdName=ms1000000262909438, createdTime=Fri Mar 08 02:45:27 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=806062, encodeId=bd2080606287, content=已经投稿7天了，状态还是new submission，是不是还没到编辑手里？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1572, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd1f5408686, createdName=ms1000001187261143, createdTime=Tue Aug 04 09:40:31 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2203457, encodeId=5dd8220345e9e, content=请问大家现在是先校稿，再付版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24e65466011, createdName=ms8000001858743317, createdTime=Wed May 08 15:16:58 CST 2024, time=2024-05-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2170716, encodeId=0ec321e071678, content=偏重的研究方向：血脂;糖尿病 经验分享：有没有被接受的基础研究文章啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=497, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94878476721, createdName=ms6000000946453986, createdTime=Fri Nov 24 11:41:13 CST 2023, time=2023-11-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2177085, encodeId=b5a521e7085fe, content=甲状腺激素的可以投么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=442, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72dd5503770, createdName=好吃猫111, createdTime=Mon Dec 25 14:42:01 CST 2023, time=2023-12-25, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：内分泌 经验分享：希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：心血管;糖尿病 经验分享：杂志效率很高，投稿到录用一个月内，外审意见很专业，统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=555, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, beContent=niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3533, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=)]

2016-07-14 camille2015

你好！请教一下，单纯细胞实验没有动物实验的话，这个杂志容易接收吗？机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表::
审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的

niniya731 2016-03-24 发表:: 审稿时间：约1个月 1月6号投稿，1月25号一审补实验，3月22日修回，3月24日接收，3月24日通知交版面费。效率还是挺高的

3533 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务